Locations
Cambridge, MA, USA · Cambridge, MA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Seed
founded in
2022
Passkey Therapeutics is a pioneering biotech company focused on developing Synergistic Multifunctional Therapeutics (SMThs) that target rare combinations of proteins to address complex diseases such as cancer, autoimmune disorders, and neurodegenerative diseases. Utilizing their proprietary platform, Locksmith, they leverage biological complexity to create innovative treatment options, positioning themselves as leaders in the biotech space with a commitment to improving patient outcomes. Their experienced team, comprised of veterans from the biotech and pharma industries, is dedicated to advancing drug discovery and development in a challenging landscape.
Something looks off?